FDA campaign H-0471-2026
Class IIHazard
potential Clostridium botulinum contamination
Distribution
Product is distributed nationwide through 31 different retail customers and direct to consumers through online sales.
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.